 |
Top 10 Prostate cancer treatment startups in USA
Feb 23, 2025 | By Jason Kwon | 18 |
1
Funding: $925.9M
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
2
Funding: $220M
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
3
Funding: $219.5M
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
4
Funding: $208.3M
Halda is developing RIPTAC therapeutics - a new class of precision medicines to defeat cancer.
Halda is developing RIPTAC therapeutics - a new class of precision medicines to defeat cancer.
5
Funding: $110M
Artera offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients
Artera offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients
6
Funding: $95M
Lantern Pharma is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action.
Lantern Pharma is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action.
7
Funding: $90M
Convergent Therapeutics is a pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate cancers
Convergent Therapeutics is a pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate cancers
8
Funding: $43M
Ezra develops technology for detecting cancer early using MRI & AI. Starting with prostate cancer.
Ezra develops technology for detecting cancer early using MRI & AI. Starting with prostate cancer.
9
Funding: $34.3M
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.
10
Funding: $25.5M
Talus Bio is a drug discovery biotech startup that develops drugs targeting undruggable transcription factors using AI.
Talus Bio is a drug discovery biotech startup that develops drugs targeting undruggable transcription factors using AI.
11
Funding: $200K
BERG is a biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments.
BERG is a biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments.
13
Funding: $6.9M
Gregor Diagnostics is focusing on the development of an at-home test to screen for prostate cancer, and differentiate between indolent and aggressive forms of the cancer.
Gregor Diagnostics is focusing on the development of an at-home test to screen for prostate cancer, and differentiate between indolent and aggressive forms of the cancer.
14
Dendreon was a biotechnology company produces immunotherapy for prostate cancer. Its cancer vaccine uses a patient’s own immune cells, which are collected, processed and infused back into the individual through an intravenous infusion that is completed in three cycles.
15
Funding: $1.5M
Bot Image develops software ProstatID - for post processing MRI using cloud based computing, physician workstation integration, and AI image interpretation to provide highly accurate prostate cancer diagnostics.
Bot Image develops software ProstatID - for post processing MRI using cloud based computing, physician workstation integration, and AI image interpretation to provide highly accurate prostate cancer diagnostics.
